Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing valproic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproic acid 150 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Sodium valproate |
Is a |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Valproic acid measurement |
Component |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate blood measurement |
Component |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Serum sodium valproate measurement (procedure) |
Component |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Valproate |
Is a |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Valproic acid 250mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Measurement of free valproic acid (procedure) |
Component |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Valproic acid 500mg delayed release capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing valproic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing valproic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproate sodium 100mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Valproate semisodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Sodium valproate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Valpromide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproic acid 150 mg gastro-resistant oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproic acid 150 mg gastro-resistant oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 250 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to valproic acid |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only valproic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproic acid only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproic acid 50 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Valproic acid 50 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Congenital malformation caused by valproic acid |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Adverse reaction caused by valproic acid (disorder) |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |
Poisoning caused by valproic acid (disorder) |
Causative agent (attribute) |
True |
Valproic acid (substance) |
Inferred relationship |
Some |
1 |